• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-淀粉样蛋白负荷与脑萎缩率无关。

Beta-amyloid burden is not associated with rates of brain atrophy.

作者信息

Josephs Keith A, Whitwell Jennifer L, Ahmed Zeshan, Shiung Maria M, Weigand Stephen D, Knopman David S, Boeve Bradley F, Parisi Joseph E, Petersen Ronald C, Dickson Dennis W, Jack Clifford R

机构信息

Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

Ann Neurol. 2008 Feb;63(2):204-12. doi: 10.1002/ana.21223.

DOI:10.1002/ana.21223
PMID:17894374
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2735194/
Abstract

OBJECTIVE

To test the hypothesis that beta-amyloid (Abeta) burden is associated with rates of brain atrophy.

METHODS

Forty-five subjects who had been prospectively studied, died, and had an autopsy diagnosis of low, intermediate, or high probability of Alzheimer's disease who had two volumetric head magnetic resonance imaging scans were identified. Compact and total (compact + diffuse) Abeta burden was measured using a computerized image analyzer with software program to detect the proportion of gray matter occupied by Abeta. Visual ratings of Abeta burden were also performed. The boundary shift integral was used to calculate change over time in whole-brain and ventricular volume. All boundary shift integral results were annualized by adjusting for scan interval. Demographics, cognitive measures, clinical diagnoses, apolipoprotein E genotype, neurofibrillary tangle (NFT) pathology, and vascular lesion burden were determined.

RESULTS

There was no correlation between compact or total Abeta burden, or visual Abeta ratings, and rates of brain loss or ventricular expansion in all subjects. However, significant correlations were observed between rates of brain loss and age, Braak NFT stage, and change over time in cognitive measures. These features also correlated with rates of ventricular expansion. The rates of brain loss and ventricular expansion were greater in demented compared with nondemented subjects.

INTERPRETATION

These findings suggest that rate of brain volume loss is not determined by the amount of insoluble Abeta in the gray matter.

摘要

目的

检验β-淀粉样蛋白(Aβ)负荷与脑萎缩率相关的假说。

方法

确定了45名经过前瞻性研究、死亡且尸检诊断为阿尔茨海默病低、中或高概率并进行过两次头颅容积磁共振成像扫描的受试者。使用配备软件程序的计算机图像分析仪测量紧密型和总(紧密型+弥漫型)Aβ负荷,以检测Aβ占据的灰质比例。还对Aβ负荷进行了视觉评分。边界位移积分用于计算全脑和脑室体积随时间的变化。所有边界位移积分结果均通过调整扫描间隔进行年化处理。确定了人口统计学特征、认知测量、临床诊断、载脂蛋白E基因型、神经纤维缠结(NFT)病理学和血管病变负荷。

结果

在所有受试者中,紧密型或总Aβ负荷、视觉Aβ评分与脑萎缩率或脑室扩大之间均无相关性。然而,观察到脑萎缩率与年龄、Braak NFT分期以及认知测量随时间的变化之间存在显著相关性。这些特征也与脑室扩大率相关。与非痴呆受试者相比,痴呆受试者的脑萎缩率和脑室扩大率更高。

解读

这些发现表明,脑容量损失率并非由灰质中不溶性Aβ的量决定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0118/2735194/2065d23bcd1e/nihms137272f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0118/2735194/3c2f92d524ad/nihms137272f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0118/2735194/d03ab7300a04/nihms137272f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0118/2735194/2065d23bcd1e/nihms137272f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0118/2735194/3c2f92d524ad/nihms137272f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0118/2735194/d03ab7300a04/nihms137272f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0118/2735194/2065d23bcd1e/nihms137272f3.jpg

相似文献

1
Beta-amyloid burden is not associated with rates of brain atrophy.β-淀粉样蛋白负荷与脑萎缩率无关。
Ann Neurol. 2008 Feb;63(2):204-12. doi: 10.1002/ana.21223.
2
Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease.载脂蛋白 E 对阿尔茨海默病淀粉样蛋白负荷和神经元病理学生物标志物的影响。
Ann Neurol. 2010 Mar;67(3):308-16. doi: 10.1002/ana.21953.
3
Relationship between atrophy and beta-amyloid deposition in Alzheimer disease.阿尔茨海默病中萎缩与β-淀粉样蛋白沉积的关系。
Ann Neurol. 2010 Mar;67(3):317-24. doi: 10.1002/ana.21955.
4
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease.阿尔茨海默病典型病例中体内PiB-PET淀粉样蛋白成像的尸检相关性
Brain. 2008 Jun;131(Pt 6):1630-45. doi: 10.1093/brain/awn016. Epub 2008 Mar 12.
5
Oligomeric Abeta in Alzheimer's disease: relationship to plaque and tangle pathology, APOE genotype and cerebral amyloid angiopathy.阿尔茨海默病中的寡聚 Aβ:与斑块和缠结病理、APOE 基因型和脑淀粉样血管病的关系。
Brain Pathol. 2010 Mar;20(2):468-80. doi: 10.1111/j.1750-3639.2009.00321.x. Epub 2009 Jul 16.
6
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.脑β-淀粉样蛋白测量和磁共振成像萎缩均能预测从轻度认知障碍到阿尔茨海默病的进展时间。
Brain. 2010 Nov;133(11):3336-48. doi: 10.1093/brain/awq277. Epub 2010 Oct 8.
7
Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.APOE基因分型对阿尔茨海默病中淀粉样斑块负荷及灰质体积的影响。
Neurology. 2009 Apr 28;72(17):1487-94. doi: 10.1212/WNL.0b013e3181a2e8d0. Epub 2009 Apr 1.
8
Effect Modifiers of TDP-43-Associated Hippocampal Atrophy Rates in Patients with Alzheimer's Disease Neuropathological Changes.TDP-43 相关的阿尔茨海默病神经病理改变患者海马萎缩率的修饰因子。
J Alzheimers Dis. 2020;73(4):1511-1523. doi: 10.3233/JAD-191040.
9
Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.可溶性纤维前体tau蛋白和β-淀粉样蛋白在早期人类阿尔茨海默病中出现,并与疾病进展和认知衰退相关。
Acta Neuropathol. 2016 Dec;132(6):875-895. doi: 10.1007/s00401-016-1632-3. Epub 2016 Oct 21.
10
Human apolipoprotein E redistributes fibrillar amyloid deposition in Tg-SwDI mice.人载脂蛋白E在Tg-SwDI小鼠中重新分布纤维状淀粉样蛋白沉积。
J Neurosci. 2008 May 14;28(20):5312-20. doi: 10.1523/JNEUROSCI.1042-08.2008.

引用本文的文献

1
Correlating retinal and choroidal vascular parameters with volumetric MRI in Alzheimer's disease and amnestic mild cognitive impairment.阿尔茨海默病和遗忘型轻度认知障碍中视网膜和脉络膜血管参数与容积MRI的相关性研究
BMC Ophthalmol. 2025 Jul 1;25(1):365. doi: 10.1186/s12886-025-04157-x.
2
Lemborexant ameliorates tau-mediated sleep loss and neurodegeneration in males in a mouse model of tauopathy.在tau蛋白病小鼠模型中,lemborexant可改善雄性小鼠tau蛋白介导的睡眠丧失和神经退行性变。
Nat Neurosci. 2025 May 27. doi: 10.1038/s41593-025-01966-7.
3
Localization of Network-Level Atrophy in Preclinical Alzheimer's Disease.临床前阿尔茨海默病中网络水平萎缩的定位
Res Sq. 2025 May 5:rs.3.rs-5977523. doi: 10.21203/rs.3.rs-5977523/v1.
4
Explainable Artificial Intelligence in Neuroimaging of Alzheimer's Disease.阿尔茨海默病神经影像学中的可解释人工智能
Diagnostics (Basel). 2025 Mar 4;15(5):612. doi: 10.3390/diagnostics15050612.
5
Soluble Aβ pathology predicts neurodegeneration and cognitive decline independently on p-tau in the earliest Alzheimer's continuum: Evidence across two independent cohorts.在最早的阿尔茨海默病连续体中,可溶性淀粉样β蛋白病理独立于磷酸化tau蛋白预测神经退行性变和认知衰退:来自两个独立队列的证据。
Alzheimers Dement. 2025 Feb;21(2):e14415. doi: 10.1002/alz.14415. Epub 2025 Feb 3.
6
Current insights into apolipoprotein E and the immune response in Alzheimer's disease.当前对载脂蛋白 E 与阿尔茨海默病免疫反应的认识。
Immunol Rev. 2024 Oct;327(1):43-52. doi: 10.1111/imr.13414. Epub 2024 Oct 24.
7
Microglial responses partially mediate the effect of Aβ on cognition in Alzheimer's disease.小胶质细胞反应部分介导了阿尔茨海默病中 Aβ 对认知的影响。
Alzheimers Dement. 2024 Nov;20(11):8028-8037. doi: 10.1002/alz.14298. Epub 2024 Oct 11.
8
Live-cell visualization of tau aggregation in human neurons.人神经元中 tau 聚集的活细胞可视化。
Commun Biol. 2024 Sep 14;7(1):1143. doi: 10.1038/s42003-024-06840-z.
9
Modeling Alzheimer's disease using human cell derived brain organoids and 3D models.利用人类细胞衍生的脑类器官和3D模型模拟阿尔茨海默病。
Front Neurosci. 2024 Aug 1;18:1434945. doi: 10.3389/fnins.2024.1434945. eCollection 2024.
10
The characteristics of brain atrophy prior to the onset of Alzheimer's disease: a longitudinal study.阿尔茨海默病发病前脑萎缩的特征:一项纵向研究。
Front Aging Neurosci. 2024 May 28;16:1344920. doi: 10.3389/fnagi.2024.1344920. eCollection 2024.

本文引用的文献

1
An estimate of the total worldwide societal costs of dementia in 2005.2005年全球痴呆症社会总成本的估计数。
Alzheimers Dement. 2007 Apr;3(2):81-91. doi: 10.1016/j.jalz.2007.02.001.
2
Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report.匹兹堡化合物B分子成像在尸检中得到证实:一例病例报告。
Arch Neurol. 2007 Mar;64(3):431-4. doi: 10.1001/archneur.64.3.431.
3
Rates of cerebral atrophy differ in different degenerative pathologies.脑萎缩的发生率在不同的退行性病变中有所不同。
Brain. 2007 Apr;130(Pt 4):1148-58. doi: 10.1093/brain/awm021. Epub 2007 Mar 8.
4
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide.神经退行性变中的可溶性蛋白质寡聚体:来自阿尔茨海默病淀粉样β肽的启示
Nat Rev Mol Cell Biol. 2007 Feb;8(2):101-12. doi: 10.1038/nrm2101.
5
Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study.阿尔茨海默病中的淀粉样蛋白负荷与脑萎缩:一项¹¹C-PIB正电子发射断层扫描研究
Ann Neurol. 2006 Jul;60(1):145-7. doi: 10.1002/ana.20889.
6
Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects.衰老过程中脑萎缩进展的危险因素:正常受试者的六年随访
Neurology. 2005 May 24;64(10):1704-11. doi: 10.1212/01.WNL.0000161871.83614.BB.
7
Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease.β-淀粉样蛋白免疫疗法(AN1792)对阿尔茨海默病脑容量MRI测量指标的影响。
Neurology. 2005 May 10;64(9):1563-72. doi: 10.1212/01.WNL.0000159743.08996.99.
8
Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.β淀粉样蛋白免疫疗法(AN1792)在一项中断试验中对阿尔茨海默病患者的临床疗效。
Neurology. 2005 May 10;64(9):1553-62. doi: 10.1212/01.WNL.0000159740.16984.3C.
9
Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of z score images.早发型和晚发型轻度阿尔茨海默病基于体素的形态学比较及Z评分图像诊断性能评估
AJNR Am J Neuroradiol. 2005 Feb;26(2):333-40.
10
Apolipoprotein E epsilon 4 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration.载脂蛋白Eε4是tau蛋白病、α-突触核蛋白病和额颞叶变性中阿尔茨海默病型病理特征的一个决定因素。
Arch Neurol. 2004 Oct;61(10):1579-84. doi: 10.1001/archneur.61.10.1579.